ATX
3 549
0,4%
DAX
20 017
0,4%
Dow
44 718
-0,1%
EStoxx50
4 879
0,7%
Nasdaq
21 198
0,2%
Öl
73,7
2,4%
Euro
1,0508
0,1%
CHF
0,9313
0,0%
Gold
2 642
0,1%
ATX
3 549
0,4%
DAX
20 017
0,4%
Dow
44 742
-0,1%
EStoxx50
4 879
0,7%
Nasdaq
21 210
0,2%
Öl
73,7
2,4%
Euro
1,0508
0,1%
CHF
0,9313
0,0%
Gold
2 642
0,1%
Depot
Menu
+ Börse
Aktien
Aktienkurse
Aktien-Suche
Realtimekurse
ATX-Liste
ATX Prime-Liste
EuroStoxx-Liste
DAX-Liste
Dow Jones-Liste
Nikkei225-Liste
S&P500-Liste
Rohstoffe
Devisen
Listen
TopFlop
Indizes
Branchen
Termine
Hauptversammlung
Quartalszahlen
Wirtschaftsdaten
Dividendenausschüt.
Dividenden
Börse-Social
Female Finance
Indizes
Listen
TopFlop
Indizes
Realtimekurse
Indizes
Listen
Emerging Markets
Zertifikate
Suche
Basiswerte
Indizes
Aktien
Baskets
Währungen
Rohstoffe
Zinsen / Anleihen
Sonstige
Produkttypen
Airbag
Aktienanleihen
Alpha
Basket
Bonus
Discount
Exotische OS
Express
Faktor Tracker
Index/Tracker
Inline-OS
Garantie
Knock-Out
Optionsscheine
Outperformance
sonst. Zertifikate
Sprint
Tools
Zertifikate-Matrix
Emittenten-Matrix
Knock-Out Map
News
Neuemissionen
Hebelprodukte
OS-Suche
KO-Suche
Basiswerte
Indizes
Aktien
Baskets
Währungen
Rohstoffe
Zinsen / Anleihen
Sonstige
Produkttypen
Airbag
Aktienanleihen
Alpha
Basket
Bonus
Discount
Exotische OS
Express
Faktor Tracker
Index/Tracker
Inline-OS
Garantie
Knock-Out
Optionsscheine
Outperformance
sonst. Zertifikate
Sprint
Tools
Zertifikate-Matrix
Emittenten-Matrix
Knock-Out Map
News
Neuemissionen
Fonds
Suche
News
KVGs
ETF
Suche
News
KVGs
Anleihen
Suche
News
Rohstoffe
News
Realtimekurse
Goldmünzen
Devisen
News
Währungsrechner
Realtimekurse
Kryptowährungen
Krypto-Broker Vergleich
Zinsen
News
Libor
Euribor
Leitzins
CFDs
News
Trading
Hebelprodukte
Optionsscheine
Realtimekurse
ATX-Liste
ATX Prime-Liste
EuroStoxx-Liste
DAX-Liste
Rohstoffe
Devisen
Bitcoin kaufen
Kryptos
Broker-Vergleiche
Broker-Vergleich
Krypto-Broker-Vergleich
CFD-Broker-Vergleich
Forum
+ News & Analysen
News
Ressorts
Aktien
Anleihen
CFDs
Devisen
ETF
Fonds
Rohstoffe
Zertifikate
Private Finanzen
Zinsen
Rubriken
Chartanalysen
Emittentennews
Fondsgesellschaft News
Heute im Fokus
Interviews
Konjunktur
Zinsen
Quellen
APA
Aktiencheck
Businesswire
Dow Jones Newswires
dpa-AFX
Heute im Fokus
Nachrichtenarchiv
Analysen
Experten Kolumnen
ATX News
+ myfinanzen
Anmelden
Registrieren
Passwort vergessen
Mein Profil
Portfolio
Watchlist
ZERO Depot
ETF-Sparplan
Krypto kaufen
Ratgeber
Suchen
Anmelden
Registrieren?
Fan werden
Börse
News & Analysen
myfinanzen
ZERO Depot
ETF-Sparplan
Krypto kaufen
Ratgeber
News
Analysen
Experten Kolumnen
ATX News
Ressorts
Aktien
Anleihen
CFDs
Devisen
ETF
Fonds
Rohstoffe
Zertifikate
Private Finanzen
Zinsen
Rubriken
Chartanalysen
Emittentennews
Fondsgesellschaft News
Heute im Fokus
Interviews
Konjunktur
Zinsen
Quellen
APA
Aktiencheck
Businesswire
Dow Jones Newswires
dpa-AFX
Heute im Fokus
Nachrichtenarchiv
Home
»
Aktien
»
IMPLANET-Aktie
»
Nachrichten zu IMPLANET
IMPLANET Aktie [WKN DE: A1W8RN / ISIN: FR0010458729]
Kurse + Charts + Realtime
News + Analysen
Fundamental
Unternehmen
zugeh. Wertpapiere
Aktion
Kurs + Chart
Chart (groß)
News + Adhoc
Bilanz/GuV
Termine
Zertifikate
Portfolio
Times + Sales
Chartvergleich
Analysen
Schätzungen
Profil
Optionsscheine
Watchlist
Börsenplätze
Realtime Push
Kursziele
Dividende/GV
Knock-Outs
Analysen
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
Nachrichten zu IMPLANET SA
Relevant
Alle
vom Unternehmen
27.02.18
IMPLANET and L&K BIOMED Have Finalized Their Partnership with Cross-Distribution Agreements Covering Asia and Europe
(Businesswire)
30.01.18
IMPLANET: Update on the L&K BIOMED Partnership
(Businesswire)
23.01.18
IMPLANET: 2017 Revenue of €7.8 Million
(Businesswire)
17.01.18
Successful First Surgical Procedures with the Jazz Lock® in Brasil
(Businesswire)
08.01.18
Implanet Announces Its Annual Report on the Liquidity Contract with Tradition Securities and Futures (TSAF)
(Businesswire)
04.01.18
Implanet Announces Its 2018 Financial Calendar
(Businesswire)
19.12.17
IMPLANET fully paid off the Kreos bond loan
(Businesswire)
06.12.17
IMPLANET Announces the Signature of a MOU on a Worldwide Partnership with Korean Company L&K BIOMED
(Businesswire)
30.11.17
Implanet Announces: Liquidity Contract Transferred From ODDO Corporate Finance to Tradition Securities And Futures (TSAF)
(Businesswire)
02.11.17
Implanet Raises 1.75 Million with U.S. Investors
(Businesswire)
24.10.17
Implanet Presents JAZZ® Results at NASS Annual Meeting, Addressing Unmet Clinical Needs in Complex Spine Surgery
(Businesswire)
19.10.17
Implanet Announces CE Mark Clearance for JAZZ® Passer
(Businesswire)
10.10.17
Implanet: 20% Increase in Revenue In Q3 2017
(Businesswire)
26.09.17
Implanet Strengthens JAZZ Intellectual Property Portfolio
(Businesswire)
19.09.17
Implanet Announces 2017 First-Half Results
(Businesswire)
12.09.17
Implanet Announces Clearance of the New JAZZ™ Passer
(Businesswire)
05.09.17
Implanet Presents Independent Radiological Results of the JAZZ Band at the SRS 52nd Annual Meeting & Course
(Businesswire)
18.07.17
Implanet Announces H1 2017 Revenue
(Businesswire)
07.07.17
Implanet Announces Its Half-Yearly Report on the Liquidity Contract With ODDO Corporate Finance
(Businesswire)
10.05.17
Shareholders Approve the Transfer of the Implanet SA Listing to the Alternext Market in Paris
(Businesswire)
18.04.17
Implanet Announces Q1 2017 Revenue
(Businesswire)
14.03.17
Implanet Strengthens Its Presence in Australia and New Zealand by Signing an Exclusive Distribution Partnership
(Businesswire)
13.12.16
Implanet Announces Its 2017 Financial Calendar
(Businesswire)
06.12.16
Implanet Presents JAZZ Band Clinical Results in Hypokyphotic Idiopathic Scoliosis Patients
(Businesswire)
15.11.16
Implanet Successfully Completes Capital Increase with Shareholders’ Preferential Subscription Rights
(Businesswire)
20.10.16
Implanet launches a share capital increase with shareholders’ preferential subscription rights for approximately €6.9 million
(Businesswire)
10.10.16
Implanet Announces Q3 2016 Sales of €1.5 Million
(Businesswire)
23.09.16
Implanet Announces Its 2016 First-Half Results: Buoyant Growth in Revenue and Substantial Gross Margin Improvement
(Businesswire)
22.09.16
Implanet Announces Its 2016 First-Half Results: Buoyant Growth in Revenue and Substantial Gross Margin Improvement
(Businesswire)
14.09.16
IMPLANET: Successful First Surgical Procedures with the New Jazz Lock® Implant
(Businesswire)
30.08.16
Implanet Strengthens Intellectual Property Protection of JAZZ Through 2032 by Obtaining a Key United States Patent
(Businesswire)
12.07.16
Implanet: Q2 2016 Record Revenue of €2.1 Million with Spine Sales Growing by +68%
(Businesswire)
07.07.16
Implanet Announces Its Half-Yearly Report on the Liquidity Contract With ODDO Corporate Finance
(Businesswire)
02.06.16
IMPLANET: Nomination of a US Healthcare Reimbursement and Finance Expert to the Board of Directors
(Businesswire)
23.05.16
Implanet: Launch of the New JAZZ Claw® Implant
(Businesswire)
29.04.16
Implanet Announces the Filling of Its Registration Document
(Businesswire)
28.04.16
Implanet: Q1 2016 revenues
(Businesswire)
13.04.16
Implanet Commences Trading on OTCQX in the U.S.
(Businesswire)
05.04.16
Implanet: Green Light for a New Implant: JAZZ Lock®
(Businesswire)
30.03.16
Implanet Announces 2015 Annual Results
(Businesswire)
14.03.16
Implanet Initiates a Prospective and Multicenter Clinical Study in Partnership with TFS International
(Businesswire)
09.03.16
Implanet to Participate at the Roth Capital 28th Conference in California
(Businesswire)
08.02.16
Implanet Announces the Appointment of Brian T. Ennis to Head Its US Subsidiary
(Businesswire)
03.02.16
Implanet to Participate at the 2016 BIO CEO Conference in New York
(Businesswire)
28.01.16
IMPLANET: Completion of the First JAZZ Band Surgical Procedure in Brazil, Latin America’s Largest Market
(Businesswire)
26.01.16
IMPLANET: 2015 Sales Growth (Excluding Hip): +6% to €6.7 Million
(Businesswire)
05.01.16
Implanet Announces Its Half-Yearly Report on the Liquidity Contract with ODDO Corporate Finance
(Businesswire)
04.01.16
Implanet Announces Its 2016 Financial Calendar
(Businesswire)
02.12.15
Implanet admitted to the SRD long-seulement Long-only Deferred Settlement Service
(Businesswire)
03.11.15
ANVISA Regulatory Approval Granted in Brazil to Market the JAZZ Band™ Platform
(Businesswire)
1
|
Weiter
Eintrag hinzufügen
Eintrag bearbeiten
Hinweis:
Sie möchten dieses Wertpapier günstig handeln?
Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision
*
pro Trade?
Hier informieren!
Erfolgreich hinzugefügt!
Zu Portfolio/Watchlist wechseln
.
Es ist ein Fehler aufgetreten!
Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben.
Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.
Portfolioname:
Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:
03.12.2024 21:53
Kaufwert:
EUR
Hinzufügen
Speichern
Newssuche
GO
Meistgelesene Nachrichten
Pierer-Aktie letztlich zweistellig höher: KTM ist insolvent - Antrag auf Sanierung in Eigenverwaltung
Ripple steigt deutlich: Neues ATH noch in 2024?
Strategische Bitcoin-Reserve: USA erwägen milliardenschweren Bitcoin-Kauf
Solana Kurs Prognose: 300 US-Dollar noch in diesem Jahr?
Novo Nordisk-Aktien und Eli Lilly-Papiere crashen: Ist der Erfolgstraum ausgträumt?
VW-Aktie unter Druck: Flächendeckender Streik bei Volkswagen - Tausende Jobs in Österreich abhänging